Login to Your Account



Nastech Licenses ED Product To Pharmacia For Up To $56M

By Kim Coghill


Tuesday, February 5, 2002

Nastech Pharmaceutical Co. Inc. licensed its nasally administered apomorphine product for sexual dysfunction in both men and women to Peapack, N.J.-based Pharmacia Corp. in a deal with a $56.4 million potential. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription